Table 3.
Stage 0/ In Situ* |
No. | Stage I ** OR ‡ (CI) § |
No. | Stage II ** OR ‡ (CI) § |
No. | Stage III ** OR ‡ (CI) § |
|
---|---|---|---|---|---|---|---|
African- American (n=679) |
|||||||
Menopause | |||||||
Yes | 64 | 151 | 0.58 (0.36, 0.95) | 119 | 0 .53 (0.32, 0.86) | 20 | 0.44 (0.21, 0.91) |
No | 34 | 141 | 1.00 | 124 | 1.00 | 26 | 1.00 |
Diabetes | |||||||
Yes | 29 | 73 | 1.23 (0.33, 4.54) | 59 | 1.34 (0.36, 5.05) | 9 | 1.36 (0.22, 8.59) |
No | 69 | 219 | 1.00 | 184 | 1.00 | 37 | 1.00 |
Diabetes Medication | |||||||
Yes | 26 | 62 | 0.69 (0.18, 2.68) | 49 | 0.60 (0.15, 2.40) | 7 | 0.44 (0.06, 3.20) |
No | 72 | 230 | 1.00 | 194 | 1.00 | 39 | 1.00 |
European- American (n=692) |
|||||||
Menopause | |||||||
Yes | 52 | 299 | 1.46 (0.83, 2.56) | 127 | 0.80 (0.44, 1.44) | 29 | 0.86 (0.38, 1.96) |
No | 22 | 83 | 1.00 | 66 | 1.00 | 14 | 1.00 |
Diabetes | |||||||
Yes | 11 | 47 | 0.40 (0.10, 1.28) | 14 | 0.25 (0.05, 1.16) | 1 | N/A*** |
No | 63 | 335 | 1.00 | 179 | 1.00 | 42 | |
Diabetes Medication | |||||||
Yes | 7 | 40 | 2.86 (0.65, 12.6) | 11 | 2.29 (0.38, 13.7) | 1 | N/A*** |
No | 67 | 342 | 1.00 | 182 | 1.00 | 42 |
Referent - Stage 0- In situ
Stage I- Localized; Stage II- Regional; Stage III- Distant
Odds Ratio
95% Confidence Interval
N/A: values do not converge due to low cell numbers (point estimate <0001)